Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Beretta

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Hepatology Communications|April 8, 2020
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South TexasSuet Ying Kwan, Jingjing Jiao, Jonathan Qi, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
Identification of osteopontin as a novel marker for early hepatocellular carcinomaSufen Shang, Amelie Plymoth, Shaokui Ge, et al.
Plos Genetics|July 7, 2011
Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse modelsKeane K Y Lai, Sufen Shang, Neha Lohia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2018
High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican AmericansGordon P Watt, Miryoung Lee, Jen-Jung Pan, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosisKwang Hwa Jung, Jing Zhang, Chong Zhou, et al.
JHEP Reports : Innovation in Hepatology|January 23, 2023
Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver diseaseJingjing Jiao, Jessica I Sanchez, Omar A Saldarriaga, et al.
The American Journal of Gastroenterology|January 31, 2019
Design of the Texas Hepatocellular Carcinoma Consortium Cohort StudyZiding Feng, Jorge A Marrero, Saira Khaderi, et al.
Cancer Research|March 15, 2015
miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor CellsJing Zhang, Jingjing Jiao, Silvia Cermelli, et al.
World Journal of Hepatology|June 19, 2015
Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohortJen-Jung Pan, Susan P Fisher-Hoch, Chaoru Chen, et al.
Molecular & Cellular Proteomics : MCP|October 16, 2007
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrenceXin Yi, John M Luk, Nikki P Lee, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Hepatology Communications|April 8, 2020
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South TexasSuet Ying Kwan, Jingjing Jiao, Jonathan Qi, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
Identification of osteopontin as a novel marker for early hepatocellular carcinomaSufen Shang, Amelie Plymoth, Shaokui Ge, et al.
Plos Genetics|July 7, 2011
Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse modelsKeane K Y Lai, Sufen Shang, Neha Lohia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2018
High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican AmericansGordon P Watt, Miryoung Lee, Jen-Jung Pan, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosisKwang Hwa Jung, Jing Zhang, Chong Zhou, et al.
JHEP Reports : Innovation in Hepatology|January 23, 2023
Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver diseaseJingjing Jiao, Jessica I Sanchez, Omar A Saldarriaga, et al.
The American Journal of Gastroenterology|January 31, 2019
Design of the Texas Hepatocellular Carcinoma Consortium Cohort StudyZiding Feng, Jorge A Marrero, Saira Khaderi, et al.
Cancer Research|March 15, 2015
miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor CellsJing Zhang, Jingjing Jiao, Silvia Cermelli, et al.
World Journal of Hepatology|June 19, 2015
Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohortJen-Jung Pan, Susan P Fisher-Hoch, Chaoru Chen, et al.
Molecular & Cellular Proteomics : MCP|October 16, 2007
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrenceXin Yi, John M Luk, Nikki P Lee, et al.
Pageof 9